Page 8 - Kleber Kiss News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kleber kiss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kleber Kiss Today - Breaking & Trending Today

Neue Struktur in der Leber entdeckt

Ein deutsches Forschungsteam konnte eine seit langem unbeantwortete Frage zum Aufbau der Leber klären. Die Arbeitsgruppe entdeckte mithilfe neuster Technologie bislang unbekannte winzige Membranstrukturen, die für den Aufbau der Gallenkanäle wichtig zu sein scheinen. Sind diese Kanäle verschlossen, können schwere Lebererkrankungen entstehen. Bisher war unklar, wie das System aus Gallenkanälchen in der Leber entsteht. ....

Volker Blasek , Mikrostruktur Has Been , Discovery May , Article So Far , Structure Can , Question About , Task Force , For The , Research Results , Oliver The , One Though Gallenfluss , Liver From The , New Diagnostic Indicator , Tiny Links , They Make , Expansion Through State , Art Mikroskopietechnologien , Studienerstautorin Lenka , Gene Was , These Effects , New Insights , Quelleninformationen Meets The Requirements , Medical Literature , Medical Guidelines As Well Current , கண்டுபிடிப்பு இருக்கலாம் , பணி படை ,

European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis


European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis
NR2E3), for the treatment of both retinitis pigmentosa (RP) and Leber Congenital amaurosis (LCA).
The prevalence of RP in Europe is estimated at approximately 165,000 patients and the prevalence of LCA in Europe is estimated at approximately 40,000 patients. Globally, the number of people suffering from RP and LCA is estimated to be around 2.0 million and 0.2 million, respectively.
We believe the granting of this designation by the European Commission validates the potential of our modifier gene therapy platform to treat many inherited retinal diseases, Chairman of the Board, Chief Executive Officer, and Co-founder of Ocugen. ....

United States , Neena Haider , Sanjay Subramanian , Emmie Twombly , Mohamed Genead , Professor Of Ophthalmology At Harvard Medical School , European Commission , Schepens Eye Research Institute , Ocugen Inc , Exchange Commission , Head Of Corporate Development , Nuclear Hormone Receptors , European Union , Leber Congenital , Chief Executive Officer , Retina Scientific Advisory Board , Acting Chief Medical Officer , Hormone Receptors , Associate Professor , Harvard Medical School , Associate Scientist , Massachusetts Eye , Bharat Biotech , Private Securities Litigation Reform Act , Financial Officer , Corporate Development ,